Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
Nadia Montero‐Oleas, Ingrid Arévalo-Rodríguez, Solange Núñez-González, et al.
BMC Complementary Medicine and Therapies (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
Arun Bhaskar, Alan Bell, Michael Boivin, et al.
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 115
A Systematic Review of Trends in US Attitudes toward Cannabis Legalization
Vivian Chiu, Wayne Hall, Gary Chan, et al.
Substance Use & Misuse (2022) Vol. 57, Iss. 7, pp. 1052-1061
Closed Access | Times Cited: 41
Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature
Dianna Wolfe, Kim Corace, Claire Butler, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281826-e0281826
Open Access | Times Cited: 30
Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
Maria de Fátima dos Santos Sampaio, Yara Bezerra de Paiva, Tuane Bazanella Sampaio, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 574-601
Open Access | Times Cited: 11
An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients
Simon Erridge, Oliver Salazar, Michal Kawka, et al.
Neuropsychopharmacology Reports (2021) Vol. 41, Iss. 3, pp. 362-370
Open Access | Times Cited: 48
Medical cannabis education among healthcare trainees: A scoping review
Yuval Zolotov, Samer Metri, Emily Calabria, et al.
Complementary Therapies in Medicine (2021) Vol. 58, pp. 102675-102675
Open Access | Times Cited: 42
A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada
Antoine Asselin, Olivier Beauparlant Lamarre, Richard Chamberland, et al.
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 26
Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms
Cláudia Carvalho, Maria Augusta Vieira‐Coelho
Pharmacological Research (2022) Vol. 181, pp. 106258-106258
Open Access | Times Cited: 24
Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection
Ana L.G. de Brito Siqueira, Pedro V.V. Cremasco, Juliana O. Bahú, et al.
Journal of Traditional and Complementary Medicine (2023) Vol. 13, Iss. 6, pp. 575-587
Open Access | Times Cited: 14
Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review
Lauren Rice, Lisa Cannon, Navin Dadlani, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 2, pp. 505-526
Open Access | Times Cited: 13
SPME as a green sample-preparation technique for the monitoring of phytocannabinoids and endocannabinoids in complex matrices
Katarzyna Woźniczka, Paweł Konieczyński, Alina Plenis, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 10, pp. 1117-1134
Open Access | Times Cited: 13
Cannabinoids for Acute Pain Management: Approaches and Rationale
Mihai Botea, Lukas Andereggen, Richard D. Urman, et al.
Current Pain and Headache Reports (2024) Vol. 28, Iss. 7, pp. 681-689
Open Access | Times Cited: 4
UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder
Mehmet Ergisi, Simon Erridge, Michael Harris, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 15, Iss. 4, pp. 487-495
Open Access | Times Cited: 28
Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
Adi Gabarin, Ludmila Yarmolinsky, Arie Budovsky, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7686-7686
Open Access | Times Cited: 12
Non-pharmacological interventions for smoking cessation: analysis of systematic reviews and meta-analyses
Tao Nian, Kangle Guo, Wendi Liu, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
THC and CBD affect metabolic syndrome parameters including microbiome in mice fed high fat-cholesterol diet
Jonathan Gorelick, Tal Assa-Glazer, Gil Zandani, et al.
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 16
Why a distinct medical stream is necessary to support patients using cannabis for medical purposes
Cecilia T. Costiniuk, Caroline A. MacCallum, Michael Boivin, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 8
A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance
Matthew Murphy, Simon Erridge, Carl Holvey, et al.
Neuropsychopharmacology Reports (2023) Vol. 44, Iss. 1, pp. 129-142
Open Access | Times Cited: 8
The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes
Farhang Modaresi, Kaivan Talachian
Pharmaceutical Medicine (2022) Vol. 36, Iss. 6, pp. 387-400
Closed Access | Times Cited: 13
“The Perfect Formula:” Evaluating Health Claims, Products and Pricing on Cannabis Dispensary Websites in Two Recently Legalized States
Samantha Hoeper, Eric Crosbie, Louisa M. Holmes, et al.
Substance Use & Misuse (2022) Vol. 57, Iss. 8, pp. 1207-1214
Open Access | Times Cited: 12
UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients
Adam Y. Li, Simon Erridge, Carl Holvey, et al.
International Clinical Psychopharmacology (2024) Vol. 39, Iss. 6, pp. 350-360
Open Access | Times Cited: 2
Application of a liquisolid technique to cannabis sativa extract compacts: Effect of liquid vehicles on the dissolution enhancement and stability of cannabinoids
Napaphak Jaipakdee, Peera Tabboon, Ekapol Limpongsa
International Journal of Pharmaceutics (2021) Vol. 612, pp. 121277-121277
Closed Access | Times Cited: 17
The cannabidiol and marijuana research expansion act: Promotion of scientific knowledge to prevent a national health crisis
John M. Purcell, Tija M. Passley, Joerg R. Leheste
The Lancet Regional Health - Americas (2022) Vol. 14, pp. 100325-100325
Open Access | Times Cited: 11
Medical Cannabis and Its Efficacy/Effectiveness for the Treatment of Low-Back Pain: a Systematic Review
Cerina Lee, Elizabeth C. Danielson, Molly Beestrum, et al.
Current Pain and Headache Reports (2023) Vol. 27, Iss. 12, pp. 821-835
Closed Access | Times Cited: 6
Therapeutic use of medical Cannabis in neurological diseases: a clinical update
Ute Hidding, Tina Mainka, Carsten Buhmann
Journal of Neural Transmission (2023) Vol. 131, Iss. 2, pp. 117-126
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top